SCHEMBL21393493

SCHEMBL21393493

COC(=O)c1ccc(COc2ccc(OC)cc2CO)nc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 2/20 0.47
MTNR1B P49286 2/20 0.47
SYK P43405 3/20 0.44
AURKB Q96GD4 2/20 0.44
INCENP Q9NQS7 2/20 0.44
KMT2A Q03164 2/20 0.44
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
TSHR P16473 1/20 0.42
P4HTM Q9NXG6 1/20 0.42
CYP2C9 P11712 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
MAPT P10636 1/20 0.42
CYP2C19 P33261 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21383273 0.83 KDM4E (0.49) KMT2ACA1CA2TDP1L3MBTL1
SCHEMBL204895 0.75 MAPK1 (0.61) KMT2ACA1CA2TDP1L3MBTL1
SCHEMBL29695095 0.75 MAPK1 (0.61) KMT2ACA1CA2TDP1L3MBTL1
SCHEMBL31734678 0.75 CSF1R (0.45) SYKKMT2ACA1CA2ALDH1A1
SCHEMBL15878428 0.74 TAS1R3 (0.52) KMT2ATDP1L3MBTL1ALDH1A1TSHR
SCHEMBL19808813 0.74 LMNA (0.47) MTNR1AMTNR1BKMT2ACA1CA2
SCHEMBL1439028 0.74 MAPK1 (0.59) KMT2ACA1CA2TDP1L3MBTL1
SCHEMBL8891941 0.74 MAPT (0.58) KMT2ACA1CA2ALDH1A1LMNA
SCHEMBL31371258 0.74 MAPT (0.58) KMT2ACA1CA2ALDH1A1LMNA
SCHEMBL7456563 0.73 MAPT (0.59) KMT2AL3MBTL1LMNATSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019182938-A1 AROMATIC ALDEHYDES WITH SUSTAINED AND ENHANCED IN VITRO AND IN VIVO PHARMACOLOGIC ACTIVITY TO TREAT SICKLE CELL DISEASE VIRGINIA COMMONWEALTH UNIVERSITY (US) 2019-09-26 WO disclosed